**7. Conclusions**

To maintain a healthy weight, diet should include a variety of foods, increased intake of fruits and vegetables, whole grains, olive oil, and nuts. Moderate intake of fish, poultry, and red wine is recommended. Consumption of foods high in sodium and sugar should be minimized. The Mediterranean diet has been shown to reduce the incidence of major cardiovascular events among patients with T2DM. Low-fat dietary patterns have been shown to reduce the risk of CVD in both primary and secondary prevention. The healthy DASH diet plan was developed to lower blood pressure and is associated with a lower risk for developing T2DM. Lowcarbohydrate diets may help prevent obesity, T2DM, and atherosclerosis.

[9] Srivastava SK, Ramana KV, Bhatnagar A. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocrine Reviews.

Dietary Recommendations for Patients with Cardiovascular Disease and Diabetes

http://dx.doi.org/10.5772/intechopen.71391

45

[10] Reaven P, Merat S, Casanada F, Sutphin M, Palinski W. Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in ldl receptor-deficient mice. Arteriosclerosis, Thrombosis,

[11] Wu L, et al. Addition of dietary fat to cholesterol in the diets of LDL receptor knockout mice: Effects on plasma insulin, lipoproteins, and atherosclerosis. Journal of Lipid

[12] Ramana KV.Aldose Reductase: New insights for an old enzyme. Biomolecular Concepts.

[13] Cameron NE, Cotter MA. Contraction and relaxation of aortas from galactosaemic rats and the effects of aldose reductase inhibition. European Journal of Pharmacology.

[14] Mulhern M, Docherty JR. Effects of experimental diabetes on the responsiveness of rat aorta. British Journal of Pharmacology. 1989;**97**(4):1007-1012. DOI: 10.1111/j.1476-

[15] Nursten HE. The Maillard reaction: Chemistry, biochemistry and implications. Journal of the American Chemical Society. 2005;**127**(41):14527-14528. DOI: 10.1021/ja059794d

[16] Ahmed MU, Dunn JA, Walla MD, Thorpe SR, Baynes JW. Oxidative degradation of glucose adducts to protein. Journal of Biological Chemistry. 1988;**263**:8816-8821

[17] Ahmed N. Advanced glycation endproducts—Role in pathology of diabetic complications. Diabetes Research and Clinical Practice. 2005;**67**:3-21. DOI: 10.1016/j. diabres.2004.09.004

[18] Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. The Korean Journal of Physiology & Pharmacology. 2014;**18**(1):1-14. DOI:

[19] Stirban A, Gawlowski T, Roden M. Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms. Molecular Metabolism. 2014;**3**(2):94-108.

[20] Vlassara H. Advanced glycation end-products and atherosclerosis. Annals of Medicine.

[21] Brownlee M, Vlassara H, Kooney T, Ulrich P, Cerami A. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science. 1986;**232**:1629-1632

[22] Meng J, Sakata N, Takebayashi S, et al. Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage. Atherosclerosis. 1998;**136**:355-365

and Vascular Biology. 1997;**17**:2250-2256. DOI: 10.1161/01.ATV.17.10.2250

Research. 2006;**47**(10):2215-2222. DOI: 10.1194/jlr.M600146-JLR200

2005;**26**:380-392. DOI: 10.1210/er.2004-0028

2011;**2**(1-2):103-114. DOI: 10.1515/BMC.2011.002

1993;**243**:47-53. DOI: 10.1016/0014-2999(93)90166-F

5381.1989. tb12555.x

10.4196/kjpp.2014.18.1.1

DOI: 10.1016/j.molmet.2013.11.006

1996;**28**:419-426. DOI: 10.3109/07853899608999102
